Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Total Debt: 2015-2024

Historic Total Debt for Syndax Pharmaceuticals (SNDX) over the last 4 years, with Dec 2024 value amounting to $343.7 million.

  • Syndax Pharmaceuticals' Total Debt was N/A to $343.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $343.7 million, marking a year-over-year change of. This contributed to the annual value of $343.7 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Syndax Pharmaceuticals reported Total Debt of $343.7 million as of FY2024, which was up 1,611.39% from $20.1 million recorded in FY2021.
  • In the past 5 years, Syndax Pharmaceuticals' Total Debt ranged from a high of $343.7 million in FY2024 and a low of $20.1 million during FY2021.
  • In the last 1 years, Syndax Pharmaceuticals' Total Debt had a median value of $343.7 million in 2024 and averaged $343.7 million.
  • Data for Syndax Pharmaceuticals' Total Debt shows a maximum YoY fell of 0.18% (in 2021) over the last 5 years.
  • Yearly analysis of 3 years shows Syndax Pharmaceuticals' Total Debt stood at $20.1 million in 2020, then dropped by 0.18% to $20.1 million in 2021, then reached $343.7 million in 2024.